✨ Free AI Report
PerkinElmer: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research PerkinElmer
Company Research

PerkinElmer: Business Overview, Financials & Competitive Analysis

PerkinElmer (PKI) is a global health technology company providing diagnostic instruments, reagents, and life sciences solutions to enable early disease detection and genomic research. The company serves pharmaceutical...

Analyst-debate audio for PerkinElmer

AskCyborg analysts argue the bull and bear cases for PerkinElmer across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
6/ 10Solid

Cyborg Score thesis

Diversified life sciences and diagnostics portfolio with strong cash generation, but near-term growth acceleration and valuation...

Read the full analyst-debate transcript →
Industry Diagnostic Laboratories
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest PerkinElmer Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

PerkinElmer Overview

Pro stress-test →

PerkinElmer (PKI) is a global health technology company providing diagnostic instruments, reagents, and life sciences solutions to enable early disease detection and genomic research. The company serves pharmaceutical, biotechnology, academic, and healthcare institutions across diagnostics, life sciences, food, and applied markets.

Strategic Profile

Pro stress-test →

PerkinElmer positions itself as a critical partner for precision diagnostics and genomic workflows, with diversified exposure spanning genetic disorder detection, infectious disease testing, and oncology research applications. The company emphasizes innovation in protein-coupled receptor and next-generation DNA sequencing technologies to support drug discovery and clinical diagnostics workflows.

Competitive Landscape

Pro stress-test →

PerkinElmer competes in diagnostics and life sciences alongside Illumina (next-generation sequencing), Waters Corporation (analytical instruments), Agilent Technologies (laboratory solutions), and Quest Diagnostics (clinical diagnostics). The company differentiates through integrated diagnostic platforms combining reagents, instruments, and genomic sequencing capabilities for early disease detection and precision medicine applications.

Industry Context

PerkinElmer operates in Diagnostic Laboratories.

Key facts

Founded: 1940 · Headquarters: Waltham, US · Employees: 16,700 · Revenue: $2.8B–$3.1B (TTM) · Market cap: $11.0B–$14.5B

What the analysts stress-tested

The top findings that survived the multi-agent debate for PerkinElmer.

  • (May 2026) Q1 2026 earnings of $0.36 EPS and $711.12M revenue with 53.7% YoY free cash flow surge, indicating robust operational cash generation
  • Diagnostics segment includes genetic disorder screening (down syndrome, hypothyroidism, muscular dystrophy), infectious disease testing, and genomic workflows for oncology and drug discovery
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • May 2026Reported Q1 2026 earnings with $0.36 EPS and $711.12M revenue; free cash flow surged 53.69% YoY
  • June 2026Announced EUR 0.07 cash dividend with ex-date July 17, 2026
  • +1 moreTrack every material event for PerkinElmer as it happens. Explore monitoring →
Get alerted when PerkinElmer has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Next-Generation SequencingLeading NGS platforms for genomic analysis→Analytical InstrumentsSeparation and analytical laboratory instruments→Laboratory SolutionsLife sciences and diagnostics lab instrumentation→Clinical DiagnosticsClinical diagnostic testing and insights→

Compare PerkinElmer with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

PerkinElmer operates in Diagnostic Laboratories. See how the rest of the sector scores on the Cyborg framework.

Browse Diagnostic Laboratories research →
NEW · MCP server

Ask your AI assistant about PerkinElmer

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare PerkinElmer and its top competitor on Cyborg Score”
“What did PerkinElmer do this quarter?”
“Is PerkinElmer a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does PerkinElmer do?+
PerkinElmer (PKI) is a global health technology company providing diagnostic instruments, reagents, and life sciences solutions to enable early disease detection and genomic research. The company serves pharmaceutical...
What is PerkinElmer's Cyborg Score?+
PerkinElmer has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are PerkinElmer's main competitors?+
Named competitors include Next-Generation Sequencing, Analytical Instruments, Laboratory Solutions, Clinical Diagnostics. The full competitive landscape is in the AskCyborg report.
How can I get the full PerkinElmer research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the PerkinElmer research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track PerkinElmer over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.